However, in comparison to HCs, the percentage of CD4+ T-cells, the CD3++CD4++CD8+/CD3+ ratio, and the CD4+/CD8+ ratio showed progressive increase in COVID-19 patients (Figure 2A). This evidence concerns the gene CD8A and COVID-19.